1. Home
  2. APGE vs WEN Comparison

APGE vs WEN Comparison

Compare APGE & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • WEN
  • Stock Information
  • Founded
  • APGE 2022
  • WEN 1969
  • Country
  • APGE United States
  • WEN United States
  • Employees
  • APGE N/A
  • WEN N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • WEN Restaurants
  • Sector
  • APGE Health Care
  • WEN Consumer Discretionary
  • Exchange
  • APGE Nasdaq
  • WEN Nasdaq
  • Market Cap
  • APGE 2.0B
  • WEN 2.1B
  • IPO Year
  • APGE 2023
  • WEN N/A
  • Fundamental
  • Price
  • APGE $37.87
  • WEN $10.33
  • Analyst Decision
  • APGE Strong Buy
  • WEN Hold
  • Analyst Count
  • APGE 5
  • WEN 17
  • Target Price
  • APGE $95.40
  • WEN $14.03
  • AVG Volume (30 Days)
  • APGE 431.7K
  • WEN 6.6M
  • Earning Date
  • APGE 08-11-2025
  • WEN 10-30-2025
  • Dividend Yield
  • APGE N/A
  • WEN 5.42%
  • EPS Growth
  • APGE N/A
  • WEN N/A
  • EPS
  • APGE N/A
  • WEN 0.96
  • Revenue
  • APGE N/A
  • WEN $2,225,413,000.00
  • Revenue This Year
  • APGE N/A
  • WEN N/A
  • Revenue Next Year
  • APGE N/A
  • WEN $3.18
  • P/E Ratio
  • APGE N/A
  • WEN $10.75
  • Revenue Growth
  • APGE N/A
  • WEN 1.31
  • 52 Week Low
  • APGE $26.20
  • WEN $9.74
  • 52 Week High
  • APGE $63.50
  • WEN $20.60
  • Technical
  • Relative Strength Index (RSI)
  • APGE 51.33
  • WEN 48.13
  • Support Level
  • APGE $35.68
  • WEN $9.95
  • Resistance Level
  • APGE $38.75
  • WEN $10.62
  • Average True Range (ATR)
  • APGE 1.59
  • WEN 0.28
  • MACD
  • APGE 0.19
  • WEN -0.00
  • Stochastic Oscillator
  • APGE 69.51
  • WEN 42.70

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: